title: The expanding role of incretin-based therapies: how much should we expect?
authors.affiliation: Third Department of Medicine, First Faculty of Medicine, General University Hospital, Charles University, Prague, Czech Republic.
authors.forename: Martin
authors.initials: M
authors.lastname: Haluzik
mesh_terms: D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*
chemical_list: D019440:Anti-Obesity Agents; D054795:Incretins